Davriellelouna@lemmy.world to News@lemmy.world · 1 month ago‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comexternal-linkmessage-square64fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-link‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comDavriellelouna@lemmy.world to News@lemmy.world · 1 month agomessage-square64fedilink
minus-squaregravitas_deficiency@sh.itjust.workslinkfedilinkEnglisharrow-up0·1 month agoPharma C-suite: that doesn’t sound very profitable I fucking wish I was kidding
minus-squarejonne@infosec.publinkfedilinkarrow-up0·1 month agoI mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
minus-squarejeffw@lemmy.worldMlinkfedilinkarrow-up0·1 month ago Pill You could read the article before you comment lol
minus-square𝔼𝕩𝕦𝕤𝕚𝕒@lemmy.worldlinkfedilinkarrow-up0·1 month ago“But how does this expand shareholder value”
Pharma C-suite:
I fucking wish I was kidding
I mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
You could read the article before you comment lol
You caught me!
“But how does this expand shareholder value”